Schrödinger is excited to be participating in the AI in Drug Discovery conference taking place on March 13th-14th in London, United Kingdom. Join us for a presentation by Dr. Jennifer Knight, Senior Principal Scientist at Schrödinger, titled “Advancing a pipeline of drug discovery programs using diverse machine learning modeling strategies”.

Speaker: Jennifer Knight, Senior Principal Scientist

Abstract: 

• Efficient profiling of large chemical space using active learning: from virtual screens to free energy calculations
• Leveraging experimental data for enhancing ADMET profiles in lead optimization
• Training DFT-quality potentials for accurate predictions of formulations
   

REGISTER